Obermeyer Wealth Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.1M | Buy |
393,332
+257,158
| +189% | +$17.7M | 1.35% | 27 |
|
|
2025
Q1 | $9.46M | Buy |
136,174
+6,070
| +5% | +$422K | 0.5% | 44 |
|
|
2024
Q4 | $11.2M | Buy |
130,104
+15,220
| +13% | +$1.31M | 0.58% | 43 |
|
|
2024
Q3 | $13.7M | Buy |
114,884
+6,206
| +6% | +$739K | 0.73% | 39 |
|
|
2024
Q2 | $15.5M | Buy |
108,678
+88,976
| +452% | +$12.7M | 0.89% | 37 |
|
|
2024
Q1 | $2.53M | Buy |
+19,702
| New | +$2.53M | 0.15% | 56 |
|
|
2013
Q3 | – | Sell |
-4,200
| Closed | -$65K | – | 209 |
|
|
2013
Q2 | $65K | Buy |
+4,200
| New | +$65K | 0.02% | 105 |
|